Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest

Liu,Bo; Gao,Yue-Qiu; Wang,Xiao-Min; Wang,Yu-Chun; Fu,Li-Qi

doi:10.3892/mmr.2014.2290

Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest

Authors:
- Bo Liu
- Yue-Qiu Gao
- Xiao-Min Wang
- Yu-Chun Wang
- Li-Qi Fu
View Affiliations

Affiliations: Department of Neurosurgery, Daqing Oilfield General Hospital, Daqing, Heilongjiang 163411, Daqing, Heilongjiang 163316, P.R. China, Department of Gastroenterology and Hepatology, The Fifth Affiliated Hospital of Harbin Medical University, Daqing, Heilongjiang 163316, P.R. China
Published online on: May 30, 2014 https://doi.org/10.3892/mmr.2014.2290
Pages: 1046-1050

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Germacrone is one of the major bioactive components of the traditional Chinese Medicinal plant Curcuma aromatica Salisb. and has been shown to possess anti‑tumor properties. In the present study, the anti‑proliferative effect of germacrone on human glioma cells and the molecular mechanism underlying its cytotoxicity were investigated. Treatment of the U87 and U251 human glioma cell lines with germacrone inhibited the cell proliferation in a dose‑ and time‑dependent manner as assessed by MTT assay, while significantly lower effects were observed on normal human astrocytes. Flow cytometric analysis and DNA fragmentation revealed that germacrone promoted apoptosis of glioma cells, associated with an increased expression of p53 and bax and decreased expression of bcl‑2. Furthermore, flow cytometric cell cycle analysis revealed that germacrone induced G1 phase arrest, associated with an obvious decrease in the expression of cyclin D1 and CDK2 and an increased expression of p21. In conclusion, the present study suggested that germacrone may be a novel potent chemopreventive drug candidate for gliomas via regulating the expression of proteins associated with apoptosis and G1 cell cycle arrest.

View Figures

View References

1	Wang Y, Zhou Z, Luo H, et al: Combination of tamoxifen and antisense human telomerase RNA inhibits glioma cell proliferation and anti-apoptosis via suppression of telomerase activity. Mol Med Rep. 3:935–940. 2010.PubMed/NCBI
2	Krakstad C and Chekenya M: Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer. 9:1352010. View Article : Google Scholar : PubMed/NCBI
3	Lefranc F, Facchini V and Kiss R: Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist. 12:1395–1403. 2007. View Article : Google Scholar : PubMed/NCBI
4	Liu YH, Li ML, Hsu MY, et al: Effects of a Chinese Herbal Medicine, Guan-Jen-Huang (Aeginetia indica Linn.), on renal cancer cell growth and metastasis. Evid Based Complement Alternat Med. 2012:9358602012.PubMed/NCBI
5	Bamba Y, Yun YS, Kunugi A and Inoue H: Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes. J Nat Med. 65:583–587. 2011.
6	Claeson P, Panthong A, Tuchinda P, et al: Three non-phenolic diarylheptanoids with anti-inflammatory activity from Curcuma xanthorrhiza. Planta Med. 59:451–454. 1993. View Article : Google Scholar : PubMed/NCBI
7	Matsuda H, Ninomiya K, Morikawa T and Yoshikawa M: Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg Med Chem Lett. 8:339–344. 1998. View Article : Google Scholar
8	Morikawa T, Matsuda H, Ninomiya K and Yoshikawa M: Medicinal foodstuffs. XXIX Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by D-galactosamine/lipopolysaccharide or tumor necrosis factor-alpha. Biol Pharm Bull. 25:627–631. 2002. View Article : Google Scholar
9	Liu Y, Wang W, Fang B, et al: Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 698:95–102. 2013. View Article : Google Scholar : PubMed/NCBI
10	Zhong Z, Chen X, Tan W, et al: Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 667:50–55. 2011. View Article : Google Scholar : PubMed/NCBI
11	Pang M, Wang ZL, Gao CL, Qu P and Li HD: Characterization of apoptotic changes induced by yessotoxin in the Bel7402 human hepatoma cell line. Mol Med Rep. 4:547–552. 2011.PubMed/NCBI
12	Gutierrez GJ, Tsuji T, Cross JV, et al: JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint. J Biol Chem. 285:14217–14228. 2010. View Article : Google Scholar : PubMed/NCBI
13	Weinert T and Hopper AK: tRNA traffic meets a cell-cycle checkpoint. Cell. 131:838–840. 2007. View Article : Google Scholar : PubMed/NCBI
14	Tanaka H, Arakawa H, Yamaguchi T, et al: A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature. 404:42–49. 2000. View Article : Google Scholar : PubMed/NCBI
15	Hu W, Ge Y, Ojcius DM, et al: p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species. Cell Microbiol. 15:1642–1659. 2013.
16	Yan X, Feng J, Ye Z, Miao X, Li W and Yang D: p53 siRNA inhibits apoptosis of U2OS cells treated with azurin. Mol Med Rep. 4:1089–1094. 2011.PubMed/NCBI
17	Deng Y and Wu X: Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc Natl Acad Sci USA. 97:12050–12055. 2000. View Article : Google Scholar : PubMed/NCBI
18	Gogada R, Prabhu V, Amadori M, Scott R, Hashmi S and Chandra D: Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem. 286:28749–28760. 2011. View Article : Google Scholar
19	Tsutsui S, Yasuda K, Suzuki K, et al: Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. BMC Cancer. 6:1872006. View Article : Google Scholar : PubMed/NCBI
20	Pirngruber J and Johnsen SA: Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3′ end processing through p21, NPAT and CDK9. Oncogene. 29:2853–2863. 2010.PubMed/NCBI
21	Satyanarayana A, Hilton MB and Kaldis P: p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell. 19:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
22	Li W, Kotoshiba S, Berthet C, Hilton MB and Kaldis P: Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition. Proc Natl Acad Sci USA. 106:486–491. 2009. View Article : Google Scholar : PubMed/NCBI
23	Chen XZ, Cao ZY, Chen TS, et al: Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncol Rep. 28:742–748. 2012.
24	Fang Y, Cao Z, Hou Q, et al: Cyclin D1 downregulation contributes to anticancer rffect of isorhapontigenin on human bladder cancer cells. Mol Cancer Ther. 12:1492–1503. 2013. View Article : Google Scholar : PubMed/NCBI
25	Grillo M, Bott MJ, Khandke N, et al: Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat. 95:185–194. 2006. View Article : Google Scholar : PubMed/NCBI